Haipharm Ltd

POWER SEARCH PRICING

SOLUTIONS

haipharm ltd Company Information

Live

EstablishedMicroDeclining

Company Number

05617699

Website

www.haipharm.com

Registered Address

elsley court, 20-22 great titchfield street, london, W1W 8BE

Industry

Other human health activities

Telephone

Next Accounts Due

August 2025

Group Structure

View All

Directors

Jennifer Lass18 Years

Amir Lass18 Years

Shareholders

jennifer susan lass 50%

amir lass 50%

haipharm ltd Estimated Valuation

£3.3m

Pomanda estimates the enterprise value of HAIPHARM LTD at £3.3m based on Net Assets of £1.3m and 2.49x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Haipharm Ltd is a live company located in london, W1W 8BE with a Companies House number of 05617699. It operates in the other human health activities sector, SIC Code 86900. Founded in November 2005, it's largest shareholder is jennifer susan lass with a 50% stake. Haipharm Ltd is a established, micro sized company, Pomanda has estimated its turnover at £92.6k with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Haipharm Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating3.5out of 5

2 Strong

3 Regular

4 Weak

Size

annual sales of £92.6k, make it smaller than the average company (£673.3k)

Growth

3 year (CAGR) sales growth of -52%, show it is growing at a slower rate (5.9%)

EXPORT

Haipharm Ltd's latest turnover from November 2023 is estimated at £92.6 thousand and the company has net assets of £1.3 million. According to their latest financial statements, Haipharm Ltd has 2 employees and maintains cash reserves of £42.9 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Nov 2023	Nov 2022	Nov 2021	Nov 2020	Nov 2019	Nov 2018	Nov 2017	Nov 2016	Nov 2015	Nov 2014	Nov 2013	Nov 2012	Nov 2011	Nov 2010	Nov 2009
Turnover	92,628	90,058	1,172,035	862,531	996,176	800,473	905,236	732,148	1,481,204	380,433	118,882	553,950	1,380,018	1,739,631	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	58,173	56,174	784,943	564,162	652,814	532,120	572,522	452,996	926,354	236,372	73,431	318,559	795,603	975,112	0
Gross Profit	34,455	33,884	387,092	298,369	343,362	268,353	332,714	279,152	554,850	144,061	45,451	235,390	584,415	764,519	0
Admin Expenses	20,739	-38,293	21,427	88,343	46,203	198,958	39,313	249,162	411,172	188,029	81,118	285,865	629,671	770,382	-376,935
Operating Profit	13,716	72,177	365,665	210,026	297,159	69,395	293,401	29,990	143,678	-43,968	-35,667	-50,475	-45,256	-5,863	376,935
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	3,848	4,067	132	81	754	1,210	762	327	609	602	659	576	566	818	505
Pre-Tax Profit	17,564	76,244	365,796	210,107	297,912	70,605	294,163	30,318	144,288	-43,366	-35,008	-49,899	-44,690	-5,045	377,440
Tax	-4,391	-14,486	-69,501	-39,920	-56,603	-13,415	-55,891	-6,063	-28,857	0	0	0	0	0	-105,683
Profit After Tax	13,173	61,758	296,295	170,187	241,309	57,190	238,272	24,254	115,430	-43,366	-35,008	-49,899	-44,690	-5,045	271,757
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	13,173	61,758	296,295	170,187	241,309	57,190	238,272	24,254	115,430	-43,366	-35,008	-49,899	-44,690	-5,045	271,757
Employee Costs	50,609	47,672	45,862	45,127	44,303	42,466	42,123	40,980	824,584	215,777	85,582	319,561	782,230	965,982	0
Number Of Employees	2	2	2	2	2	2	2	2	39	10	4	15	37	47	0
EBITDA*	14,881	72,177	365,665	210,026	297,159	69,395	293,401	30,432	144,228	-43,547	-35,351	-50,053	-44,694	-5,144	377,340

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Nov 2023	Nov 2022	Nov 2021	Nov 2020	Nov 2019	Nov 2018	Nov 2017	Nov 2016	Nov 2015	Nov 2014	Nov 2013	Nov 2012	Nov 2011	Nov 2010	Nov 2009
Tangible Assets	3,496	4,262	550	733	979	1,306	281,926	2,322	2,764	1,404	949	1,265	1,687	2,249	2,879
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	1,134,582	233,145	1,037,132	836,435	700,258	372,359	1,742	72,266	24,626	1	1	1	7,000	7,898	7,616
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	1,138,078	237,407	1,037,682	837,168	701,237	373,665	283,668	74,588	27,390	1,405	950	1,266	8,687	10,147	10,495
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	0	0	152,729	99,644	126,268	105,044	125,846	103,529	113,328	19,883	7,607	45,024	120,661	157,977	117,764
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	193,058	1,021,531	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	42,920	111,009	160,145	103,223	58,786	142,209	180,380	124,516	137,284	106,369	134,355	129,083	101,304	125,259	202,019
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	235,978	1,132,540	312,874	202,867	185,054	247,253	306,226	228,045	250,612	126,252	141,962	174,107	221,965	283,236	319,783
total assets	1,374,056	1,369,947	1,350,556	1,040,035	886,291	620,918	589,894	302,633	278,002	127,657	142,912	175,373	230,652	293,383	330,278
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	0	0	112,870	98,644	115,087	91,023	117,189	68,200	67,823	32,908	4,797	2,250	7,630	25,671	57,521
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	60,565	70,503	0	0	0	0	0	0	0	0	0	0	0	0	0
total current liabilities	60,565	70,503	112,870	98,644	115,087	91,023	117,189	68,200	67,823	32,908	4,797	2,250	7,630	25,671	57,521
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	874	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	874	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total liabilities	61,439	70,503	112,870	98,644	115,087	91,023	117,189	68,200	67,823	32,908	4,797	2,250	7,630	25,671	57,521
net assets	1,312,617	1,299,444	1,237,686	941,391	771,204	529,895	472,705	234,433	210,179	94,749	138,115	173,123	223,022	267,712	272,757
total shareholders funds	1,312,617	1,299,444	1,237,686	941,391	771,204	529,895	472,705	234,433	210,179	94,749	138,115	173,123	223,022	267,712	272,757

	Nov 2023	Nov 2022	Nov 2021	Nov 2020	Nov 2019	Nov 2018	Nov 2017	Nov 2016	Nov 2015	Nov 2014	Nov 2013	Nov 2012	Nov 2011	Nov 2010	Nov 2009
Operating Activities
Operating Profit	13,716	72,177	365,665	210,026	297,159	69,395	293,401	29,990	143,678	-43,968	-35,667	-50,475	-45,256	-5,863	376,935
Depreciation	1,165	0	0	0	0	0	0	442	550	421	316	422	562	719	405
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	-4,391	-14,486	-69,501	-39,920	-56,603	-13,415	-55,891	-6,063	-28,857	0	0	0	0	0	-105,683
Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors	-828,473	868,802	53,085	-26,624	21,224	-20,802	22,317	-9,799	93,445	12,276	-37,417	-75,637	-37,316	40,213	117,764
Creditors	0	-112,870	14,226	-16,443	24,064	-26,166	48,989	377	34,915	28,111	2,547	-5,380	-18,041	-31,850	57,521
Accruals and Deferred Income	-9,938	70,503	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Taxes & Provisions	874	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	829,899	-853,478	257,305	180,287	243,396	50,616	264,182	34,545	56,841	-27,712	4,613	20,204	-25,419	-77,207	211,414
Investing Activities
capital expenditure	-399	-3,712	183	246	327	280,620	-279,604	0	-1,910	-876	0	0	0	-89	-3,284
Change in Investments	901,437	-803,987	200,697	136,177	327,899	370,617	-70,524	47,640	24,625	0	0	-6,999	-898	282	7,616
cash flow from investments	-901,836	800,275	-200,514	-135,931	-327,572	-89,997	-209,080	-47,640	-26,535	-876	0	6,999	898	-371	-10,900
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,000
interest	3,848	4,067	132	81	754	1,210	762	327	609	602	659	576	566	818	505
cash flow from financing	3,848	4,067	132	81	754	1,210	762	327	609	602	659	576	566	818	1,505
cash and cash equivalents
cash	-68,089	-49,136	56,922	44,437	-83,423	-38,171	55,864	-12,768	30,915	-27,986	5,272	27,779	-23,955	-76,760	202,019
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-68,089	-49,136	56,922	44,437	-83,423	-38,171	55,864	-12,768	30,915	-27,986	5,272	27,779	-23,955	-76,760	202,019

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for haipharm ltd. Get real-time insights into haipharm ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for haipharm ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in W1W area or any other competitors across 12 key performance metrics.

HAIPHARM LTD group structure

Haipharm Ltd has no subsidiary companies.

Ultimate parent company

HAIPHARM LTD

05617699

HAIPHARM LTD Shareholders

jennifer susan lass	50%
amir lass	50%

Haipharm Ltd currently has 2 directors. The longest serving directors include Mrs Jennifer Lass (Nov 2005) and Dr Amir Lass (Nov 2005).

officer	country	age	start	end	role
Mrs Jennifer Lass	United Kingdom	68 years	Nov 2005	-	Director
Dr Amir Lass	United Kingdom	67 years	Nov 2005	-	Director

P&L

November 2023

turnover

92.6k

+3%

operating profit

13.7k

gross margin

37.2%

-1.14%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

November 2023

net assets

1.3m

+0.01%

total assets

1.4m

cash

42.9k

-0.61%

net assets

Total assets minus all liabilities

Similar Companies

ecospirito ltd

british geriatrics society (the)

hawkes pharmacy (moseley) limited

0.5

manna management limited

4.5

imperial health mw limited

company number

05617699

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

November 2005

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

last accounts submitted

November 2023

address

elsley court, 20-22 great titchfield street, london, W1W 8BE

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to haipharm ltd.

haipharm ltd Company Information

haipharm ltd Estimated Valuation

haipharm ltd Estimated Valuation

haipharm ltd Estimated Valuation

Haipharm Ltd Overview

Haipharm Ltd Health Check

HAIPHARM LTD financials

haipharm ltd Credit Report and Business Information

Haipharm Ltd Competitor Analysis

haipharm ltd Ownership

haipharm ltd directors

haipharm ltd company details

haipharm ltd Charges & Mortgages

haipharm ltd Companies House Filings - See Documents